Yet, directing αDC1 vaccines against endogenous DLK1 on tumor-derived stromal cells was beneficial to mice only in combination with anti-PD-1 blockade (Figure 2A; Supplementary Figure 4). The gene discussed is DLK1; the disease is neoplasm.